跳至主要内容
临床试验/NCT03786939
NCT03786939招募中不适用

Evaluation of Outcomes of Coronary Artery Bypass Grafting.

St. Petersburg State Pavlov Medical University2 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2018年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
2
主要终点
Death.

研究概览

简要总结

Evaluation of outcomes of coronary artery bypass grafting.

详细描述

Evaluation of outcomes of coronary artery bypass grafting (CABG) on-, off- pump, pump assisted as well as bimammary coronary artery bypass grafting.

Objective

To assess myocardial ischemic-reperfusion damage during different kinds of CABG.

To assess complications after during different kinds of CABG.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
30 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ischemic heart disease with indications for coronary artery bypass grafting.

排除标准

  • valve disease

结局指标

主要结局

Death.

时间窗: 30 days during in stay.

Death during in-stay.

次要结局

  • Death over 5 year after CABG.(within 5 years.)
  • Acute myocardial infarction after CABG.(within 5 years after CABG)
  • Death over 1 year after CABG.(1 year.)
  • Death over 3 year after CABG.(within 3 years.)
  • Shunt dysfunction during 30 days after CABG.(within 30 days after CABG)
  • Shunt dysfunction during 3 years after CABG.(within 3 years after CABG)
  • Shunt dysfunction during 5 years after CABG.(within 5 years after CABG)
  • Shunt dysfunction during 1 year after CABG.(within 1 year after CABG)
  • Stroke.(within 30 days after CABG)
  • Renal Dysfunction.(within 30 days after CABG)
  • Atrial fibrillation.(within 30 days after CABG)
  • IABP(within 30 days after CABG)
  • Residual myocardial ischemia.(within 30 days after CABG)
  • Infection or febrile.(within 30 days after CABG)

研究者

发起方
St. Petersburg State Pavlov Medical University
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验